A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancer

BACKGROUND: Prostate cancer (PCa), a prevalent malignant cancer in males worldwide, screening for patients might benefit more from immuno-/chemo-therapy remained inadequate and challenging due to the heterogeneity of PCa patients. Thus, the study aimed to explore the metabolic (Meta) characteristics...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, He, Gu, Jie, Tian, Yuqiu, Li, Shuyu, Zhang, Hao, Dai, Ziyu, Wang, Zeyu, Zhang, Nan, Peng, Renjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620963/
https://www.ncbi.nlm.nih.gov/pubmed/36325340
http://dx.doi.org/10.3389/fimmu.2022.982628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620963/
https://www.ncbi.nlm.nih.gov/pubmed/36325340
http://dx.doi.org/10.3389/fimmu.2022.982628

Ejemplares similares